Initiated Randomized Phase 2 Study of NUC-3373 in Patients with Colorectal Cancer
Initiated Phase 1b/2 Study of NUC-3373 in Combination with Other Agents, Including PD-1 Inhibitors, in Patients with Solid Tumors
Read more at globenewswire.comAll information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
Initiated Randomized Phase 2 Study of NUC-3373 in Patients with Colorectal Cancer
Initiated Phase 1b/2 Study of NUC-3373 in Combination with Other Agents, Including PD-1 Inhibitors, in Patients with Solid Tumors
Read more at globenewswire.com